Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Roy Copping"'
Autor:
Tara Mastren, Valery Radchenko, Allison Owens, Roy Copping, Rose Boll, Justin R. Griswold, Saed Mirzadeh, Lance E. Wyant, Mark Brugh, Jonathan W. Engle, Francois M. Nortier, Eva R. Birnbaum, Kevin D. John, Michael E. Fassbender
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-7 (2017)
Abstract A new method has been developed for the isolation of 223,224,225Ra, in high yield and purity, from a proton irradiated 232Th matrix. Herein we report an all-aqueous process using multiple solid-supported adsorption steps including a citrate
Externí odkaz:
https://doaj.org/article/c4ce5e09c2234701ae14e728aa214ee6
Coordination Characteristics of Uranyl BBP Complexes: Insights from an Electronic Structure Analysis
Autor:
Chaitanya Das Pemmaraju, Roy Copping, Danil E. Smiles, David K. Shuh, Niels Grønbech-Jensen, David Prendergast, Andrew Canning
Publikováno v:
ACS Omega, Vol 2, Iss 3, Pp 1055-1062 (2017)
Externí odkaz:
https://doaj.org/article/83d5a23cefdd46d4b9b4826fc609fb47
Autor:
Tara Mastren, Valery Radchenko, Philip D Hopkins, Jonathan W Engle, John W Weidner, Roy Copping, Mark Brugh, F Meiring Nortier, Eva R Birnbaum, Kevin D John, Michael Ernst-Heinrich Fassbender
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0190308 (2017)
Ruthenium-103 is the parent isotope of 103mRh (t1/2 56.1 min), an isotope of interest for Auger electron therapy. During the proton irradiation of thorium targets, large amounts of 103Ru are generated through proton induced fission. The development o
Externí odkaz:
https://doaj.org/article/eb2b44ace77b4b0190e5973af9c40b82
Autor:
M. Janeth Lozano-Rodriguez, Pierre Thuéry, Sébastien Petit, Roy Copping, Jose Mustre de Leon, Christophe Den Auwer
Publikováno v:
Acta Crystallographica Section E, Vol 67, Iss 4, Pp m487-m487 (2011)
The title compound, (C16H36N)3[Th(NCS)4(NO3)3], was obtained from the reaction of Th(NO3)4·5H2O with (Bu4N)(NCS). The ThIV atom is in a ten-coordinate environment of irregular geometry, being bound to the N atoms of the four thiocyanate ions and to
Externí odkaz:
https://doaj.org/article/81a4d640568b4b5f822c8f21375bd182
Autor:
Roy Copping, David A. Cullen, Saed Mirzadeh, Allison Peacock, Andrew Miskowiec, Miguel Toro-González, Sandra M. Davern
Publikováno v:
Journal of Nanotheranostics
Volume 2
Issue 1
Pages 3-50
Volume 2
Issue 1
Pages 3-50
The development of targeted alpha therapy (TAT) as a viable cancer treatment requires innovative solutions to challenges associated with radionuclide retention to enhance local tumor cytotoxicity and to minimize off-target effects. Nanoparticles (NPs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44c0f42af14d9add0adafc8303edc47c
https://doi.org/10.3390/jnt2010003
https://doi.org/10.3390/jnt2010003
Autor:
Brian E. Zimmerman, Michael K. Schultz, Mengshi Li, Keith R Olewine, Daniel R. McAlister, Anthony J DeGraffenreid, Dongyoul Lee, Roy Copping, Stephen A. Graves, Edwin A Sagastume, Frances L. Johnson, Roy H Larsen, Saed Mirzadeh
Publikováno v:
Current Medicinal Chemistry. 27:7003-7031
Receptor-targeted image-guided Radionuclide Therapy (TRT) is increasingly recognized as a promising approach to cancer treatment. In particular, the potential for clinical translation of receptor-targeted alpha-particle therapy is receiving considera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8b8f4c2b06de0dbbf8d4418c5d3b4a6
https://doi.org/10.2174/0929867327999200727190423
https://doi.org/10.2174/0929867327999200727190423
Autor:
D. Scott Wilbur, Andrew C. Akin, Eva R. Birnbaum, Mark Brugh, Michael E. Fassbender, Kevin D. John, Tara Mastren, Francois M. Nortier, Roy Copping
Publikováno v:
Nuclear Medicine and Biology. :69-73
Purpose Thorium-226 (half-life 30.6 m) is a radionuclide of interest for use in targeted alpha therapy applications. Due to its short half-life, 226Th must be provided through a radionuclide generator system from its parent 230U (20.8 d). Furthermore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fcf2666956fe80f96a5cce9c10c42cb
https://doi.org/10.1016/j.nucmedbio.2020.09.006
https://doi.org/10.1016/j.nucmedbio.2020.09.006
Autor:
Zachary, Kulage, Tyler, Cantrell, Justin, Griswold, David, Denton, Marc, Garland, Roy, Copping, Saed, Mirzadeh
Publikováno v:
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 172
The newest radioisotope for brachytherapy treatment of prostate cancer is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b317e890840c87a7e3eaf92d76e74d57
https://pubmed.ncbi.nlm.nih.gov/33689941
https://pubmed.ncbi.nlm.nih.gov/33689941
Autor:
Tara, Mastren, Andrew, Akin, Roy, Copping, Mark, Brugh, D Scott, Wilbur, Eva R, Birnbaum, Francois M, Nortier, Kevin D, John, Michael E, Fassbender
Publikováno v:
Nuclear medicine and biology.
Thorium-226 (half-life 30.6 m) is a radionuclide of interest for use in targeted alpha therapy applications. Due to its short half-life,A reverse radionuclide generator system was developed employing a DGA extraction chromatography column. AThorium-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::13f0dbd1aca13ec06e2ada3e48f87d6b
https://pubmed.ncbi.nlm.nih.gov/33068963
https://pubmed.ncbi.nlm.nih.gov/33068963